Disclosure: We may earn a commission if you buy through links on this page — at no extra cost to you. Learn more.
Statements on this site have not been evaluated by the Food and Drug Administration.
Products and information are not intended to diagnose, treat, cure, or prevent any disease. Learn More
Products and information are not intended to diagnose, treat, cure, or prevent any disease. Learn More
Summary
Citicoline (CDP‑Choline) is a choline donor and cytidine source that supports phospholipid synthesis and neurotransmission. In adults, supplementation may modestly improve attention and mental clarity, with signals for memory and mood in select populations over 8–12+ weeks.
Our Picks
CoQ10 — Thorne
Supports cardiovascular and neurological health, cellular energy production, and healthy aging with well-absorbed CoQ10. NSF Certified for Sport®.
Mental Clarity, Focus, and Energy
- Attention and processing speed: RCTs show small improvements in attention and cognitive performance, particularly in individuals with low baseline choline status or cognitive complaints.
- Mental energy: Some studies report improved subjective mental energy and reduced errors on sustained tasks; effects accumulate with consistent dosing.
- Moderators: Dose (500–1,000 mg/day), baseline status, and duration (≥8 weeks) influence outcomes.
Brain Health
- Mechanisms: Increases choline availability for acetylcholine synthesis; supports phosphatidylcholine and membrane repair; may enhance dopaminergic signaling in select pathways.
- Human data: Benefits most evident in mild cognitive concerns and attention metrics; disease‑modifying effects are not established.
Gut Health
- Generally low GI side‑effect profile at standard doses; occasional nausea or abdominal discomfort possible. Take with food if sensitive.
- Direct microbiome or barrier effects in humans are not well characterized.
Brain-Gut Axis
- Indirect pathway via improved attention and mood may reduce stress‑related gut symptoms; no definitive human trials connecting citicoline to gut–brain outcomes.
Evidence Summary
Benefit Area | Evidence Quality | Effect Noted | Notes |
Mental Clarity | Moderate | Improved attention and processing speed | 500–1,000 mg/day; ≥8–12 weeks |
Focus Enhancement | Moderate | Reduced errors on sustained tasks | Greatest with consistent dosing |
Energy Support | Limited–Moderate | Increased subjective mental energy | Not a stimulant |
Brain Health | Limited–Moderate | Membrane and neurotransmitter support | Heterogeneous endpoints |
Gut Health | Limited | Low GI adverse events | Take with food if needed |
Brain–Gut Optimization | Emerging | Indirect via mood and stress | Insufficient direct trials |
Typical Dosing Instructions
- Standard dose: 500–1,000 mg/day (e.g., 250–500 mg once or twice daily)
- Timing: Morning or early afternoon; avoid late‑day dosing if sensitive to alertness
- Form: Citicoline (CDP‑Choline) capsules or powder from reputable manufacturers
- Notes: Allow 8–12 weeks for cognitive endpoints; can be paired with omega‑3s in some protocols
Safety Considerations
- General safety: Generally well tolerated at standard doses
- Common effects: Headache, restlessness, or GI discomfort in a minority of users
- Contraindications and cautions: Use caution with other cholinergic agents; rare reports of insomnia at higher or late doses
- Populations: Limited data in pregnancy or pediatrics; avoid unless clinician‑directed
- Monitoring: Track attention metrics, subjective mental energy, and sleep; reduce dose or shift earlier if insomnia occurs
References
- Citicoline (CDP‑Choline) in cognitive impairment and neurological disorders: an update, Drugs, 2016-01-15
- Citicoline improves attention and psychomotor performance in middle‑aged and older adults: randomized, double‑blind, placebo‑controlled trial, International Journal of Neuroscience, 2012-06-01
- Citicoline for cognitive and behavioral disturbances in cerebrovascular disease: systematic review and meta‑analysis, Stroke, 2014-09-01
- CDP‑Choline (Citicoline): mechanisms of action and clinical uses, CNS Drugs, 2013-05-10
- Citicoline supplementation, brain bioenergetics, and cognition: magnetic resonance spectroscopy and behavioral outcomes, Food and Nutrition Sciences, 2015-11-20